Doo-Hun Kim
Vermögen: 149 502 $ am 31.05.2026
Vermögen: 149 502 $ am 31.05.2026
Doo-Hun Kim currently works at Feyman Asset Management Co., Ltd., as Chief Executive Officer and AbClon, Inc., as Chief Financial Officer & Executive Director from 2024.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABCLON, INC. 0,03 % | 27.04.2026 | 6.000 ( 0,03 % ) | 149 502 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ABCLON INC. | Finanzdirektor/CFO | 28.03.2024 |
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 2 |
|---|---|
Feyman Asset Management Co., Ltd.
Feyman Asset Management Co., Ltd. Investment ManagersFinance FAM is an active, GARP-oriented, team-based investment manager which concentrates on high-performance stock in the electronics, finance, chemical, iron/steel manufacturing and transportation equipment manufacturing industries. The firm primarily manages stock/bond combination funds and money market funds. They apply a combination of bottom-up and top-down approaches in the composition of portfolios, and consider both value and growth firms. In addition, industry-specific analysis takes up an important role, while risk management is achieved through sector-rotating and evaluation against a benchmark. | Finance |
AbClon, Inc.
AbClon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of antibody drugs | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen